- Australia
- /
- Real Estate
- /
- ASX:UOS
ASX Penny Stocks To Watch In March 2025
Reviewed by Simply Wall St
The Australian market has shown a mixed performance, with the ASX200 closing slightly up by 0.07% at 7,942 points, driven by gains in the IT and Health Care sectors. Investing in penny stocks—though an outdated term—still holds relevance today as these typically smaller or newer companies can offer unique growth opportunities when supported by solid financial health. In light of current market conditions, we will explore three penny stocks that stand out for their potential to combine affordability with resilience.
Top 10 Penny Stocks In Australia
Name | Share Price | Market Cap | Rewards & Risks |
CTI Logistics (ASX:CLX) | A$1.675 | A$130.67M | ✅ 4 ⚠️ 2 View Analysis > |
Accent Group (ASX:AX1) | A$1.805 | A$1.02B | ✅ 4 ⚠️ 1 View Analysis > |
EZZ Life Science Holdings (ASX:EZZ) | A$1.565 | A$73.83M | ✅ 4 ⚠️ 2 View Analysis > |
IVE Group (ASX:IGL) | A$2.44 | A$377.93M | ✅ 4 ⚠️ 2 View Analysis > |
GTN (ASX:GTN) | A$0.655 | A$128.63M | ✅ 3 ⚠️ 2 View Analysis > |
West African Resources (ASX:WAF) | A$2.20 | A$2.51B | ✅ 4 ⚠️ 1 View Analysis > |
Bisalloy Steel Group (ASX:BIS) | A$3.12 | A$148.04M | ✅ 3 ⚠️ 2 View Analysis > |
Regal Partners (ASX:RPL) | A$2.54 | A$851.91M | ✅ 5 ⚠️ 3 View Analysis > |
NRW Holdings (ASX:NWH) | A$2.80 | A$1.28B | ✅ 5 ⚠️ 1 View Analysis > |
LaserBond (ASX:LBL) | A$0.395 | A$46.35M | ✅ 3 ⚠️ 2 View Analysis > |
Click here to see the full list of 979 stocks from our ASX Penny Stocks screener.
Let's uncover some gems from our specialized screener.
EMVision Medical Devices (ASX:EMV)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: EMVision Medical Devices Ltd focuses on the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring in Australia, with a market cap of A$169.75 million.
Operations: The company's revenue segment is derived entirely from the research and development of medical device technology, amounting to A$8.06 million.
Market Cap: A$169.75M
EMVision Medical Devices, with a market cap of A$169.75 million, is pre-revenue and focuses on neurodiagnostic technology. Despite being unprofitable, it has reduced losses over the past five years by 3.5% annually. The company has sufficient short-term assets (A$17.3M) to cover both its short-term (A$2M) and long-term liabilities (A$2.4M), and more cash than debt, indicating financial stability for now. Recent inclusion in the S&P/ASX All Ordinaries Index may boost visibility among investors, although its net loss increased significantly to A$3.57 million for the half-year ended December 2024 compared to the previous year.
- Click here and access our complete financial health analysis report to understand the dynamics of EMVision Medical Devices.
- Gain insights into EMVision Medical Devices' past trends and performance with our report on the company's historical track record.
MyState (ASX:MYS)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: MyState Limited, with a market cap of A$420.47 million, operates in Australia offering banking, trustee, and managed fund products and services through its subsidiaries.
Operations: The company's revenue is derived from its Banking segment, generating A$137.91 million, and its Wealth Management segment, contributing A$16.11 million.
Market Cap: A$420.47M
MyState Limited, with a market cap of A$420.47 million, recently merged with Auswide Bank Ltd., expanding its reach across Australia's eastern seaboard under multiple brands. The company's financial stability is supported by a predominantly low-risk funding structure, with 74% of liabilities from customer deposits and an appropriate level of bad loans at 1%. Although earnings growth has been negative recently, the company maintains high-quality earnings and trades below estimated fair value. However, its return on equity is low at 7.2%, and it has experienced an unstable dividend track record alongside decreased net profit margins year-over-year.
- Click here to discover the nuances of MyState with our detailed analytical financial health report.
- Evaluate MyState's prospects by accessing our earnings growth report.
United Overseas Australia (ASX:UOS)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: United Overseas Australia Ltd, along with its subsidiaries, is involved in the development and resale of land and buildings across Malaysia, Singapore, Vietnam, and Australia with a market capitalization of A$958.58 million.
Operations: The company's revenue is primarily derived from its land development and resale segment, which generated A$354.29 million, and its investment activities, contributing A$236.66 million.
Market Cap: A$958.58M
United Overseas Australia Ltd, with a market cap of A$958.58 million, demonstrates financial stability through its strong asset base, as short-term assets of A$1.6 billion exceed both short- and long-term liabilities. Despite a recent decline in net profit margins to 50.3% from 57%, the company achieved earnings growth of 15.6% last year, surpassing industry averages. Its seasoned management team and board contribute to strategic consistency, while its debt is well-managed with cash flow coverage at 20.7%. The price-to-earnings ratio of 10.5x suggests potential value compared to the broader Australian market's average of 17.4x.
- Dive into the specifics of United Overseas Australia here with our thorough balance sheet health report.
- Examine United Overseas Australia's past performance report to understand how it has performed in prior years.
Turning Ideas Into Actions
- Click this link to deep-dive into the 979 companies within our ASX Penny Stocks screener.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Ready For A Different Approach?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Jump on the AI train with fast growing tech companies forging a new era of innovation.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:UOS
United Overseas Australia
Engages in the development and resale of land and buildings in Malaysia, Singapore, Vietnam, and Australia.
Excellent balance sheet with acceptable track record.
Similar Companies
Market Insights
Community Narratives
